RENOVORX, INC. Operating Lease Right-of-Use Assets
RENOVORX, INC. (RNXT) had Operating Lease Right-of-Use Assets of $368.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-13
- 2026-06-30: Operating Lease, Right-of-Use Asset $368.00K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $167.00K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $190.00K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $213.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $368.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $167.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $190.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $213.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $235.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $256.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $278.00K 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |